APON(SZ:300753) Xin Lang Cai Jing·2025-10-16 03:18Group 1 - The core viewpoint of the news is that Aipeng Medical has seen a stock price increase of 5.07%, reaching 30.45 CNY per share, with a trading volume of 240 million CNY and a turnover rate of 9.16%, resulting in a total market capitalization of 3.838 billion CNY [1] - Aipeng Medical, established on October 30, 2001, and listed on December 13, 2018, specializes in the development, production, and sales of medical devices in the fields of pain management and nasal care [1] - The company's main business revenue composition includes pain management products at 59.73%, nasal and upper airway products at 29.40%, and other products at 10.87% [1] Group 2 - From the perspective of fund holdings, Beixin Ruifeng Fund has one fund heavily invested in Aipeng Medical, specifically the Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056), which holds 120,000 shares, accounting for 4.43% of the fund's net value, ranking as the tenth largest holding [2] - The Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056) was established on March 27, 2015, with a latest scale of 89.3779 million CNY, and has achieved a year-to-date return of 29.73%, ranking 2969 out of 8161 in its category [2] - The fund has a one-year return of 32.8%, ranking 2786 out of 8021, and a cumulative return since inception of 23.5% [2]